Go Pro

Xponential Fitness (XPOF) Financials

Xponential Fitness logo
$6.11 -0.17 (-2.68%)
Closing price 03:59 PM Eastern
Extended Trading
$6.10 -0.02 (-0.28%)
As of 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Xponential Fitness

Annual Income Statements for Xponential Fitness

This table shows Xponential Fitness' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-37 -14 -19 1.22 -4.00 -68 -39
Consolidated Net Income / (Loss)
-37 -14 -51 1.10 -6.44 -99 -54
Net Income / (Loss) Continuing Operations
-37 -14 -51 7.81 -6.44 -99 -54
Total Pre-Tax Income
-37 -13 -51 1.59 -5.41 -99 -52
Total Operating Income
-21 7.79 -31 13 35 -54 20
Total Gross Profit
82 72 114 197 242 239 250
Total Revenue
129 107 155 243 318 320 315
Operating Revenue
129 107 155 243 318 320 315
Total Cost of Revenue
47 34 41 46 76 81 65
Operating Cost of Revenue
47 34 41 46 76 81 65
Total Operating Expenses
103 65 145 166 207 293 230
Selling, General & Admin Expense
80 61 94 127 169 177 152
Marketing Expense
8.22 7.10 13 17 23 27 40
Depreciation Expense
6.39 7.65 10 15 17 18 12
Other Operating Expenses / (Income)
7.95 -11 27 2.44 -18 8.89 -6.95
Impairment Charge
- - 0.78 3.66 17 63 33
Total Other Income / (Expense), net
-16 -21 -20 -23 -40 -45 -72
Interest Expense
16 21 21 13 39 46 77
Interest & Investment Income
0.17 0.35 1.16 1.81 1.61 1.82 3.21
Other Income / (Expense), net
- - - -12 -3.19 -1.00 1.10
Income Tax Expense
0.16 0.37 0.78 0.49 1.03 -0.34 1.32
Net Income / (Loss) Attributable to Noncontrolling Interest
0.00 0.00 -33 -0.11 -2.44 -31 -15
Basic Earnings per Share
$0.00 $0.00 ($2.85) ($0.88) $1.08 ($2.27) ($1.47)
Weighted Average Basic Shares Outstanding
0.00 0.00 22.40M 25.30M 31.74M 32.00M 34.80M
Diluted Earnings per Share
$0.00 $0.00 ($2.85) ($0.88) ($0.52) ($2.27) ($1.47)
Weighted Average Diluted Shares Outstanding
0.00 0.00 22.40M 25.30M 39.71M 32.00M 34.80M
Weighted Average Basic & Diluted Shares Outstanding
- - 46.89M 49.27M 47.49M 48.48M 49.05M

Quarterly Income Statements for Xponential Fitness

This table shows Xponential Fitness' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
-3.38 -9.02 -2.48 -9.56 -12 -44 -1.92 0.97 -4.86 -33 -0.73
Consolidated Net Income / (Loss)
-5.18 -14 -3.75 -14 -18 -63 -2.66 1.35 -6.75 -46 -0.82
Net Income / (Loss) Continuing Operations
-5.18 -14 -3.75 -14 -18 -63 -2.66 1.35 -6.75 -46 -0.82
Total Pre-Tax Income
-4.98 -13 -3.80 -14 -18 -63 -2.17 1.66 -6.48 -45 -0.81
Total Operating Income
7.48 -1.82 7.99 -3.09 -6.61 -52 9.68 15 3.57 -8.22 13
Total Gross Profit
64 65 60 57 58 63 61 62 62 66 54
Total Revenue
80 89 80 77 81 84 77 76 79 83 61
Operating Revenue
80 89 80 77 81 84 77 76 79 83 61
Total Cost of Revenue
16 24 20 20 22 21 16 14 17 17 6.89
Operating Cost of Revenue
16 24 20 20 22 21 16 14 17 17 6.89
Total Operating Expenses
57 67 52 60 65 115 51 47 58 74 41
Selling, General & Admin Expense
44 53 37 37 46 57 46 24 25 58 30
Marketing Expense
5.82 6.39 6.52 7.85 6.42 5.89 9.36 8.86 8.98 13 12
Depreciation Expense
4.22 4.18 4.44 4.52 4.23 4.53 2.96 2.97 3.68 2.42 2.25
Other Operating Expenses / (Income)
-1.92 -1.03 4.52 -1.22 3.66 1.92 -8.64 -1.92 3.07 0.53 -3.19
Impairment Charge
4.67 - 0.00 12 4.51 - 1.92 13 18 0.31 0.00
Total Other Income / (Expense), net
-12 -11 -12 -11 -11 -11 -12 -13 -10 -37 -14
Interest Expense
11 11 12 11 12 12 11 13 13 39 14
Interest & Investment Income
0.02 0.42 0.36 0.39 0.48 0.59 0.62 0.70 1.09 0.80 0.64
Income Tax Expense
0.20 0.82 -0.05 0.13 0.13 -0.56 0.49 0.31 0.27 0.26 0.01
Net Income / (Loss) Attributable to Noncontrolling Interest
-1.80 -4.79 -1.27 -4.78 -6.03 -19 -0.74 0.38 -1.89 -13 -0.10
Basic Earnings per Share
$0.91 $0.11 ($0.29) ($0.30) ($0.29) ($1.39) ($0.10) ($0.01) ($0.18) ($1.18) ($0.02)
Weighted Average Basic Shares Outstanding
32.26M 31.74M 31.13M 31.81M 32.18M 32.00M 33.91M 34.97M 35.11M 34.80M 37.32M
Diluted Earnings per Share
($0.50) $1.27 ($0.29) ($0.30) ($0.29) ($1.39) ($0.10) ($0.01) ($0.18) ($1.18) ($0.02)
Weighted Average Diluted Shares Outstanding
40.22M 39.71M 31.13M 31.81M 32.18M 32.00M 33.91M 34.97M 35.11M 34.80M 37.32M
Weighted Average Basic & Diluted Shares Outstanding
47.46M 47.49M 48.07M 48.18M 48.30M 48.48M 48.67M 48.84M 48.91M 49.05M 49.18M

Annual Cash Flow Statements for Xponential Fitness

This table details how cash moves in and out of Xponential Fitness' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
-1.87 1.96 10 16 -0.28 -4.36 13
Net Cash From Operating Activities
1.55 -0.73 14 52 33 12 28
Net Cash From Continuing Operating Activities
1.55 -0.73 14 52 33 12 28
Net Income / (Loss) Continuing Operations
-37 -14 -51 1.10 -6.44 -99 -54
Consolidated Net Income / (Loss)
-37 -14 -51 1.10 -6.44 -99 -54
Depreciation Expense
6.39 7.65 10 15 17 18 12
Amortization Expense
0.53 3.10 8.45 0.74 3.41 4.36 7.91
Non-Cash Adjustments To Reconcile Net Income
7.04 5.88 8.25 33 47 74 66
Changes in Operating Assets and Liabilities, net
25 -3.71 39 1.41 -28 14 -3.85
Net Cash From Investing Activities
-9.78 -4.60 -51 -15 -12 -14 1.53
Net Cash From Continuing Investing Activities
-9.78 -4.60 -51 -15 -12 -14 1.53
Purchase of Property, Plant & Equipment
-7.23 -1.88 -3.64 -8.96 -7.43 -4.71 -3.58
Acquisitions
-1.03 -1.01 -46 -7.18 -4.35 -10 -1.60
Sale of Property, Plant & Equipment
2.01 0.06 1.25 3.30 0.84 0.88 0.18
Divestitures
- - - - 0.00 0.00 6.71
Other Investing Activities, net
-3.53 -1.77 -2.71 -1.78 -0.75 0.00 -0.17
Net Cash From Financing Activities
6.36 7.29 46 -21 -21 -1.88 -17
Net Cash From Continuing Financing Activities
6.36 7.29 46 -21 -21 -1.88 -17
Repayment of Debt
-4.34 -172 -312 -3.03 -4.61 -44 -394
Repurchase of Preferred Equity
0.00 0.00 -20 0.00 -131 0.00 0.00
Repurchase of Common Equity
0.00 0.00 -3.08 0.00 -50 0.00 0.00
Payment of Dividends
0.00 -73 -31 -17 -19 -15 -6.17
Issuance of Debt
12 199 256 7.43 189 63 516
Issuance of Preferred Equity
0.00 0.00 198 0.00 0.00 0.00 0.00
Issuance of Common Equity
0.00 0.00 122 0.00 0.00 0.21 0.19
Other Financing Activities, net
-1.30 54 -164 -9.15 -5.36 -6.16 -133
Cash Interest Paid
13 17 16 12 35 41 38
Cash Income Taxes Paid
0.17 0.23 1.40 2.79 1.57 0.56 0.21

Quarterly Cash Flow Statements for Xponential Fitness

This table details how cash moves in and out of Xponential Fitness' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents
12 -15 -9.88 -1.20 12 -5.04 9.83 -3.89 2.78 4.40 -24
Net Cash From Operating Activities
7.63 -5.48 2.68 3.00 5.22 0.76 5.82 2.52 9.30 11 -22
Net Cash From Continuing Operating Activities
7.63 -5.48 2.68 3.00 5.22 0.76 5.82 2.52 9.30 11 -22
Net Income / (Loss) Continuing Operations
-5.18 -14 -3.75 -14 -18 -63 -2.66 1.35 -6.75 -46 -0.82
Consolidated Net Income / (Loss)
-5.18 -14 -3.75 -14 -18 -63 -2.66 1.35 -6.75 -46 -0.82
Depreciation Expense
4.22 4.18 4.44 4.52 4.23 4.53 2.96 2.97 3.68 2.42 2.25
Amortization Expense
0.93 0.96 1.40 0.93 0.98 1.05 1.38 2.37 2.37 1.79 0.86
Non-Cash Adjustments To Reconcile Net Income
14 11 2.92 15 9.78 46 6.22 16 13 31 2.32
Changes in Operating Assets and Liabilities, net
-5.88 -7.54 -2.32 -4.19 8.20 12 -2.09 -20 -2.79 21 -26
Net Cash From Investing Activities
-2.98 -3.09 -9.20 -2.56 -2.17 -0.22 -1.00 -1.86 0.56 3.83 -0.62
Net Cash From Continuing Investing Activities
-2.98 -3.09 -9.20 -2.56 -2.17 -0.22 -1.00 -1.86 0.56 3.83 -0.62
Purchase of Property, Plant & Equipment
-1.80 -1.27 -0.86 -2.13 -1.83 0.10 -0.47 -1.53 -1.08 -0.51 -0.46
Acquisitions
-0.99 -1.93 -9.01 -0.51 -0.42 -0.38 -0.40 -0.40 -0.42 -0.38 -0.35
Sale of Property, Plant & Equipment
0.35 0.11 0.66 0.08 0.08 0.06 0.04 0.07 0.06 0.01 0.20
Other Investing Activities, net
-0.55 - 0.00 - - - -0.17 - - - 0.00
Net Cash From Financing Activities
7.04 -6.21 -3.35 -1.65 8.71 -5.58 5.01 -4.55 -7.08 -10 -2.08
Net Cash From Continuing Financing Activities
7.04 -6.21 -3.35 -1.65 8.71 -5.58 5.01 -4.55 -7.08 -10 -2.08
Repayment of Debt
-1.49 -1.19 -40 -1.29 -1.40 -1.35 -1.46 -1.37 -1.38 -390 -1.31
Payment of Dividends
-10 -6.17 -1.91 -0.30 -8.54 -3.94 -2.11 -2.12 -1.95 0.01 -0.14
Issuance of Debt
63 - 39 - 24 - 10 - - 506 0.00
Other Financing Activities, net
5.88 1.15 0.01 -0.14 -5.60 -0.43 -1.42 -1.18 -3.75 -127 -0.63
Cash Interest Paid
9.67 10 9.86 10 11 10 9.91 11 11 6.55 14
Cash Income Taxes Paid
0.57 -0.11 0.06 0.35 0.18 -0.02 0.09 0.14 0.02 -0.05 0.12

Annual Balance Sheets for Xponential Fitness

This table presents Xponential Fitness' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
323 416 483 530 403 346
Total Current Assets
33 51 86 97 84 95
Cash & Equivalents
11 21 37 37 33 46
Note & Lease Receivable
1.29 2.29 1.52 0.20 0.23 0.29
Accounts Receivable
5.20 12 26 32 26 18
Inventories, net
6.16 6.93 11 16 10 2.22
Prepaid Expenses
5.48 5.27 6.29 5.59 11 24
Other Current Assets
3.28 3.71 4.13 6.89 4.60 3.67
Plant, Property, & Equipment, net
14 13 19 20 15 11
Total Noncurrent Assets
276 352 378 413 305 240
Goodwill
140 169 166 171 135 128
Intangible Assets
98 137 137 120 101 67
Other Noncurrent Operating Assets
36 43 74 121 68 46
Total Liabilities & Shareholders' Equity
323 416 483 530 403 346
Total Liabilities
318 349 383 624 597 718
Total Current Liabilities
55 66 73 102 108 116
Short-Term Debt
6.77 3.94 3.04 4.76 5.40 5.25
Accounts Payable
18 15 16 19 27 26
Accrued Expenses
14 21 12 20 31 51
Current Deferred Revenue
14 23 32 35 26 19
Other Current Liabilities
1.80 3.25 9.27 24 18 14
Total Noncurrent Liabilities
263 283 310 522 490 602
Long-Term Debt
176 128 133 319 342 501
Noncurrent Deferred Revenue
74 96 109 117 106 70
Other Noncurrent Operating Liabilities
13 60 67 86 42 32
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest
0.00 277 308 115 117 0.00
Total Equity & Noncontrolling Interests
4.75 -210 -208 -210 -311 -372
Total Preferred & Common Equity
4.75 -654 -155 -130 -217 -269
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
4.75 -654 -155 -130 -217 -269
Common Stock
114 0.00 505 521 504 490
Retained Earnings
-107 -644 -642 -634 -702 -741
Treasury Stock
- 0.00 -1.70 -1.70 -1.70 -1.70
Other Equity Adjustments
-1.46 -11 -16 -15 -17 -17
Noncontrolling Interest
0.00 444 -53 -80 -94 -103

Quarterly Balance Sheets for Xponential Fitness

This table presents Xponential Fitness' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets
472 484 545 551 508 475 472 412 400 355 322
Total Current Assets
80 79 97 117 88 86 96 100 103 99 75
Cash & Equivalents
31 28 40 52 27 26 38 43 39 41 21
Note & Lease Receivable
1.93 1.50 1.50 1.11 0.07 0.35 0.28 0.38 0.29 5.41 0.10
Accounts Receivable
19 22 27 28 32 30 30 29 37 19 21
Inventories, net
14 13 12 16 15 13 11 8.32 7.39 5.66 2.50
Prepaid Expenses
11 9.92 12 14 5.66 8.24 8.34 15 15 23 26
Other Current Assets
3.57 4.08 4.26 6.51 7.33 8.07 9.02 5.26 4.81 4.57 3.91
Plant, Property, & Equipment, net
17 19 21 20 19 19 19 15 14 12 10
Total Noncurrent Assets
375 386 427 414 401 371 358 297 283 244 237
Goodwill
166 166 171 166 174 163 163 135 128 128 128
Intangible Assets
140 135 125 122 124 120 118 99 94 67 66
Other Noncurrent Operating Assets
67 85 131 125 103 88 77 63 61 49 44
Total Liabilities & Shareholders' Equity
472 484 545 551 508 475 472 412 400 355 322
Total Liabilities
396 536 568 628 600 576 596 609 596 559 694
Total Current Liabilities
81 77 100 102 92 92 94 123 113 93 99
Short-Term Debt
3.04 4.26 4.26 5.20 5.15 5.15 5.40 5.50 5.50 10 5.25
Accounts Payable
23 19 27 24 25 23 21 28 23 16 18
Accrued Expenses
19 14 15 13 13 14 21 47 43 33 42
Current Deferred Revenue
29 31 35 37 30 29 29 25 24 24 21
Other Current Liabilities
6.62 8.55 20 22 19 20 17 18 16 10 13
Total Noncurrent Liabilities
315 459 467 527 508 484 501 486 483 466 595
Long-Term Debt
132 258 257 319 319 318 342 352 353 349 500
Capital Lease Obligations
- - - - - - - - - 16 13
Noncurrent Deferred Revenue
108 111 113 115 116 111 109 102 100 79 68
Other Noncurrent Operating Liabilities
75 90 97 92 73 54 51 33 31 22 14
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest
257 227 182 130 123 123 117 117 117 117 0.00
Total Equity & Noncontrolling Interests
-181 -279 -204 -207 -214 -224 -240 -314 -313 -321 -372
Total Preferred & Common Equity
-127 -223 -158 -138 -144 -152 -156 -225 -225 -230 -316
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
-127 -223 -158 -138 -144 -152 -156 -225 -225 -230 -316
Common Stock
529 438 486 503 506 508 517 498 497 497 444
Retained Earnings
-642 -639 -621 -624 -633 -642 -654 -704 -703 -708 -741
Treasury Stock
- -1.70 -1.70 -1.70 -1.70 -1.70 -1.70 -1.70 -1.70 -1.70 -1.70
Other Equity Adjustments
-14 -20 -22 -15 -16 -16 -17 -17 -18 -19 -17
Noncontrolling Interest
-54 -56 -46 -69 -70 -72 -84 -89 -88 -90 -56

Annual Metrics And Ratios for Xponential Fitness

This table displays calculated financial ratios and metrics derived from Xponential Fitness' official financial filings.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
0.00 0.00 46,863,026.00 - - - 48,907,000.00
DEI Adjusted Shares Outstanding
0.00 0.00 46,863,026.00 - - - 48,907,000.00
DEI Earnings Per Adjusted Shares Outstanding
0.00 0.00 -0.40 - - - -0.79
Growth Metrics
- - - - - - -
Revenue Growth
0.00% -17.45% 45.49% 56.82% 30.73% 0.76% -1.71%
EBITDA Growth
0.00% 231.13% -165.77% 244.69% 194.78% -162.57% 225.64%
EBIT Growth
0.00% 137.02% -495.42% 105.16% 1,895.78% -272.21% 138.35%
NOPAT Growth
0.00% 137.02% -495.42% 142.79% 164.67% -253.60% 137.02%
Net Income Growth
0.00% 63.27% -277.13% 102.14% -685.20% -1,431.83% 45.62%
EPS Growth
0.00% 0.00% 0.00% 69.12% 40.91% -336.54% 35.24%
Operating Cash Flow Growth
0.00% -147.03% 2,085.03% 260.28% -37.17% -64.30% 142.51%
Free Cash Flow Firm Growth
0.00% 0.00% 86.89% 44.34% 349.61% 9.76% 35.82%
Invested Capital Growth
0.00% 0.00% 0.46% 12.25% -3.35% -37.31% -26.96%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 9.03% 6.07% -1.95% -0.08%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% -18.39% 27.80% -192.62% 1,525.49%
EBIT Q/Q Growth
0.00% 0.00% 0.00% -67.47% 58.10% -11,155.06% 186.62%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% 170.04% 37.41% -3,667.13% 183.23%
Net Income Q/Q Growth
0.00% 0.00% 0.00% 104.15% -192.11% -119.02% 23.89%
EPS Q/Q Growth
0.00% 0.00% 0.00% 82.44% -333.33% -582.98% 12.50%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 102.96% 8.47% -37.56% 43.40% 53.77%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 1,066.24% 237.82% 16.67%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% 10.24% -1.70% -35.38% -32.31%
Profitability Metrics
- - - - - - -
Gross Margin
63.50% 67.99% 73.39% 80.90% 76.00% 74.63% 79.44%
EBITDA Margin
-10.95% 17.39% -7.86% 7.25% 16.36% -10.16% 12.98%
Operating Margin
-16.30% 7.31% -19.87% 5.48% 10.98% -16.74% 6.30%
EBIT Margin
-16.30% 7.31% -19.87% 0.65% 9.97% -17.05% 6.65%
Profit (Net Income) Margin
-28.76% -12.80% -33.17% 0.45% -2.03% -30.81% -17.05%
Tax Burden Percent
100.44% 102.78% 101.55% 69.29% 119.12% 99.65% 102.53%
Interest Burden Percent
175.62% -170.27% 164.37% 100.00% -17.06% 181.35% -249.95%
Effective Tax Rate
0.00% 0.00% 0.00% 30.71% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 6.19% -12.21% 4.91% 12.51% -24.02% 13.34%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% -16.08% -33.39% -2.86% -3.51% -44.37% -4.11%
Return on Net Nonoperating Assets (RNNOA)
0.00% -580.63% -132.34% -3.59% -263.16% 92.35% 5.63%
Return on Equity (ROE)
0.00% -574.44% -144.56% 1.32% -250.65% 68.33% 18.97%
Cash Return on Invested Capital (CROIC)
0.00% -193.81% -12.67% -6.63% 15.92% 21.85% 44.50%
Operating Return on Assets (OROA)
0.00% 2.41% -8.35% 0.35% 6.27% -11.71% 5.59%
Return on Assets (ROA)
0.00% -4.23% -13.93% 0.25% -1.27% -21.16% -14.33%
Return on Common Equity (ROCE)
0.00% -574.44% 1,319.58% -6.43% 13,884.67% 81.98% 16.28%
Return on Equity Simple (ROE_SIMPLE)
0.00% -287.22% 7.86% -0.71% 4.96% 45.57% 0.00%
Net Operating Profit after Tax (NOPAT)
-15 5.46 -22 9.23 24 -38 14
NOPAT Margin
-11.41% 5.12% -13.91% 3.80% 7.69% -11.72% 4.41%
Net Nonoperating Expense Percent (NNEP)
0.00% 22.27% 21.18% 7.77% 16.01% 20.34% 17.45%
Return On Investment Capital (ROIC_SIMPLE)
- - - -12.82% 21.34% -103.32% 10.38%
Cost of Revenue to Revenue
36.50% 32.01% 26.61% 19.10% 24.00% 25.37% 20.56%
SG&A Expenses to Revenue
62.34% 57.15% 60.63% 52.14% 53.11% 55.21% 48.27%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
79.80% 60.68% 93.26% 68.05% 65.02% 91.36% 73.13%
Earnings before Interest and Taxes (EBIT)
-21 7.79 -31 1.59 32 -55 21
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-14 19 -12 18 52 -33 41
Valuation Ratios
- - - - - - -
Price to Book Value (P/BV)
0.00 33.69 0.00 0.00 0.00 0.00 0.00
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
1.24 1.50 6.18 4.64 1.92 0.00 1.28
Price to Earnings (P/E)
0.00 0.00 0.00 928.88 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.11% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 1.88 10.11 7.46 4.86 0.00 8.64
Enterprise Value to Revenue (EV/Rev)
0.00 3.11 11.54 6.09 2.94 0.00 2.41
Enterprise Value to EBITDA (EV/EBITDA)
0.00 17.88 0.00 84.00 17.95 0.00 18.58
Enterprise Value to EBIT (EV/EBIT)
0.00 42.53 0.00 932.71 29.44 0.00 36.26
Enterprise Value to NOPAT (EV/NOPAT)
0.00 60.76 0.00 160.54 38.22 0.00 54.67
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 123.82 28.47 28.54 0.00 26.82
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 30.03 0.00 16.39
Leverage & Solvency
- - - - - - -
Debt to Equity
0.00 38.49 1.99 1.36 -3.42 -1.79 -1.36
Long-Term Debt to Equity
0.00 37.06 1.93 1.33 -3.37 -1.76 -1.35
Financial Leverage
0.00 36.11 3.96 1.26 75.01 -2.08 -1.37
Leverage Ratio
0.00 67.98 10.37 5.40 196.89 -3.23 -1.32
Compound Leverage Factor
0.00 -115.75 17.05 5.40 -33.58 -5.86 3.31
Debt to Total Capital
0.00% 97.47% 66.51% 57.64% 141.40% 226.69% 378.00%
Short-Term Debt to Total Capital
0.00% 3.61% 1.99% 1.29% 2.08% 3.52% 3.92%
Long-Term Debt to Total Capital
0.00% 93.86% 64.52% 56.35% 139.32% 223.17% 374.07%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 363.43% 107.92% 15.33% 14.74% -76.88%
Common Equity to Total Capital
0.00% 2.53% -329.94% -65.56% -56.73% -141.43% -201.11%
Debt to EBITDA
0.00 9.86 -10.82 7.71 6.23 -10.67 12.37
Net Debt to EBITDA
0.00 9.25 -9.07 5.59 5.52 -9.66 11.25
Long-Term Debt to EBITDA
0.00 9.49 -10.50 7.54 6.14 -10.50 12.24
Debt to NOPAT
0.00 33.50 -6.12 14.74 13.26 -9.25 36.40
Net Debt to NOPAT
0.00 31.43 -5.13 10.69 11.74 -8.38 33.10
Long-Term Debt to NOPAT
0.00 32.26 -5.93 14.41 13.07 -9.11 36.02
Altman Z-Score
0.00 0.16 -0.44 0.45 -0.30 0.00 -1.63
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 1,012.86% 586.20% 5,639.43% -19.97% 14.19%
Liquidity Ratios
- - - - - - -
Current Ratio
0.00 0.60 0.78 1.18 0.95 0.78 0.82
Quick Ratio
0.00 0.32 0.54 0.89 0.67 0.60 0.56
Cash Flow Metrics
- - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -171 -22 -12 31 34 46
Operating Cash Flow to CapEx
29.69% -39.96% 605.91% 920.83% 496.10% 304.56% 832.15%
Free Cash Flow to Firm to Interest Expense
0.00 -7.98 -1.07 -0.96 0.80 0.74 0.61
Operating Cash Flow to Interest Expense
0.10 -0.03 0.69 4.00 0.84 0.25 0.37
Operating Cash Flow Less CapEx to Interest Expense
-0.23 -0.12 0.57 3.57 0.67 0.17 0.33
Efficiency Ratios
- - - - - - -
Asset Turnover
0.00 0.33 0.42 0.54 0.63 0.69 0.84
Accounts Receivable Turnover
0.00 20.51 18.35 13.06 11.12 10.12 14.21
Inventory Turnover
0.00 5.54 6.31 5.22 5.77 6.35 10.58
Fixed Asset Turnover
0.00 7.78 11.72 15.54 16.72 18.76 24.66
Accounts Payable Turnover
0.00 1.86 2.48 2.99 4.39 3.56 2.43
Days Sales Outstanding (DSO)
0.00 17.79 19.89 27.96 32.81 36.06 25.69
Days Inventory Outstanding (DIO)
0.00 65.91 57.89 69.90 63.26 57.49 34.49
Days Payable Outstanding (DPO)
0.00 196.19 147.02 122.15 83.23 102.45 150.21
Cash Conversion Cycle (CCC)
0.00 -112.49 -69.25 -24.29 12.84 -8.90 -90.02
Capital & Investment Metrics
- - - - - - -
Invested Capital
0.00 176 177 199 192 120 88
Invested Capital Turnover
0.00 1.21 0.88 1.29 1.63 2.05 3.02
Increase / (Decrease) in Invested Capital
0.00 176 0.81 22 -6.66 -72 -32
Enterprise Value (EV)
0.00 331 1,789 1,482 934 0.00 760
Market Capitalization
160 160 958 1,129 612 0.00 403
Book Value per Share
$0.00 $0.36 ($13.96) ($3.14) ($2.74) ($6.77) ($5.50)
Tangible Book Value per Share
$0.00 ($17.48) ($20.49) ($9.30) ($8.87) ($14.15) ($9.47)
Total Capital
0.00 188 198 236 229 153 134
Total Debt
0.00 183 132 136 324 347 506
Total Long-Term Debt
0.00 176 128 133 319 342 501
Net Debt
0.00 171 111 99 287 314 460
Capital Expenditures (CapEx)
5.21 1.82 2.39 5.65 6.59 3.83 3.40
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 -27 -32 -21 -38 -51 -62
Debt-free Net Working Capital (DFNWC)
0.00 -15 -11 16 -0.49 -18 -16
Net Working Capital (NWC)
0.00 -22 -15 13 -5.25 -24 -21
Net Nonoperating Expense (NNE)
22 19 30 8.13 31 61 68
Net Nonoperating Obligations (NNO)
0.00 171 111 99 287 314 460
Total Depreciation and Amortization (D&A)
6.91 11 19 16 20 22 20
Debt-free, Cash-free Net Working Capital to Revenue
0.00% -25.09% -20.66% -8.79% -11.82% -15.95% -19.67%
Debt-free Net Working Capital to Revenue
0.00% -14.49% -6.92% 6.58% -0.16% -5.73% -5.11%
Net Working Capital to Revenue
0.00% -20.84% -9.46% 5.33% -1.65% -7.41% -6.77%
Earnings Adjustments
- - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 ($2.85) ($0.87) $1.18 ($2.27) ($1.47)
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 22.40M 25.30M 31.74M 32.00M 34.80M
Adjusted Diluted Earnings per Share
$0.00 $0.00 ($2.85) ($0.87) ($0.44) ($2.27) ($1.47)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 22.40M 25.30M 39.71M 32.00M 34.80M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 46.89M 49.27M 47.49M 48.48M 49.05M
Normalized Net Operating Profit after Tax (NOPAT)
-15 5.46 -21 12 36 6.26 37
Normalized NOPAT Margin
-11.41% 5.12% -13.56% 4.84% 11.37% 1.95% 11.69%
Pre Tax Income Margin
-28.63% -12.45% -32.67% 0.65% -1.70% -30.92% -16.63%
Debt Service Ratios
- - - - - - -
EBIT to Interest Expense
-1.31 0.36 -1.47 0.12 0.82 -1.18 0.27
NOPAT to Interest Expense
-0.92 0.25 -1.03 0.71 0.63 -0.81 0.18
EBIT Less CapEx to Interest Expense
-1.63 0.28 -1.58 -0.31 0.65 -1.26 0.23
NOPAT Less CapEx to Interest Expense
-1.24 0.17 -1.14 0.27 0.46 -0.89 0.14
Payout Ratios
- - - - - - -
Dividend Payout Ratio
0.00% -536.68% -60.87% 1,511.72% -300.06% -14.88% -11.50%
Augmented Payout Ratio
0.00% -536.68% -66.86% 1,511.72% -1,081.96% -14.88% -11.50%

Quarterly Metrics And Ratios for Xponential Fitness

This table displays calculated financial ratios and metrics derived from Xponential Fitness' official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding
- - - - - - 48,484,000.00 48,665,000.00 48,835,000.00 48,907,000.00 49,050,000.00
DEI Adjusted Shares Outstanding
- - - - - - 48,484,000.00 48,665,000.00 48,835,000.00 48,907,000.00 49,050,000.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - -0.04 0.02 -0.10 -0.67 -0.01
Growth Metrics
- - - - - - - - - - -
Revenue Growth
26.15% 28.71% 12.49% -1.06% 0.07% -6.32% -3.53% -0.90% -2.12% -0.31% -21.03%
EBITDA Growth
-29.67% 120.66% 572.01% -93.15% -111.76% -1,543.90% -2.15% 816.45% 915.83% 94.16% 24.88%
EBIT Growth
-46.01% 89.64% 187.35% -107.44% -214.98% -2,630.04% 16.38% 516.88% 180.89% 86.69% 51.75%
NOPAT Growth
-28.32% 90.16% 202.51% -104.65% -185.93% -2,769.53% 21.08% 656.52% 153.99% 84.17% 34.76%
Net Income Growth
60.30% -544.79% 70.92% -149.64% -246.71% -354.24% 29.09% 109.38% 62.83% 26.97% 69.16%
EPS Growth
67.32% -23.49% 78.26% -422.22% 42.00% -209.45% 65.52% 96.67% 37.93% 15.11% 80.00%
Operating Cash Flow Growth
-32.35% -137.56% -76.26% -84.38% -31.59% 113.90% 117.01% -15.93% 78.18% 1,276.03% -472.79%
Free Cash Flow Firm Growth
-4.90% 115.57% -75.77% -99.04% 146.08% 552.07% 643.70% 52,349.93% 1,230.73% -24.39% -98.08%
Invested Capital Growth
8.39% -3.35% 12.60% -1.00% -4.63% -37.31% -42.71% -37.50% -30.28% -26.96% 6.22%
Revenue Q/Q Growth
4.00% 11.24% -11.83% -3.78% 5.19% 4.13% -7.61% -0.88% 3.43% 5.25% -26.82%
EBITDA Q/Q Growth
-73.48% -70.03% 11.86% -77.93% -145.55% -3,580.36% 127.84% 49.01% -40.91% -123.82% 695.36%
EBIT Q/Q Growth
-84.25% -133.98% 137.61% -139.25% -143.40% -706.75% 116.51% 62.09% -61.65% -229.63% 288.32%
NOPAT Q/Q Growth
-85.57% -124.31% 150.53% -132.59% -166.86% -711.83% 118.64% 77.61% -79.26% -330.51% 258.67%
Net Income Q/Q Growth
-118.83% -166.35% 52.00% -213.64% -31.53% -248.96% 95.74% 150.62% -601.19% -576.13% 98.20%
EPS Q/Q Growth
-655.56% 354.00% -122.22% 3.33% 0.00% -379.31% 92.81% 90.00% -1,700.00% -555.56% 98.31%
Operating Cash Flow Q/Q Growth
-60.29% -171.84% 197.22% 11.35% 73.91% -85.40% 649.74% -56.63% 268.57% 14.83% -303.12%
Free Cash Flow Firm Q/Q Growth
-130.29% 154.55% -994.96% 101.76% 1,357.36% 671.89% 167.39% -9.10% -31.37% -54.67% -93.21%
Invested Capital Q/Q Growth
-1.74% -1.70% 3.25% -4.11% -5.34% -35.38% -2.33% 4.61% 5.60% -32.31% 42.05%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
79.78% 73.13% 75.46% 75.56% 72.74% 74.79% 79.10% 81.03% 78.06% 79.60% 88.65%
EBITDA Margin
13.41% 3.61% 15.86% 3.64% -1.58% -55.68% 16.82% 25.29% 14.45% -3.27% 26.60%
Operating Margin
9.30% -2.03% 9.29% -3.15% -7.98% -62.24% 12.59% 19.45% 4.52% -9.91% 21.48%
EBIT Margin
7.00% -2.14% 8.52% -3.48% -8.05% -62.34% 11.18% 18.28% 6.78% -8.35% 21.48%
Profit (Net Income) Margin
-6.44% -15.43% -5.48% -17.85% -22.33% -74.82% -3.46% 1.77% -8.56% -54.98% -1.35%
Tax Burden Percent
104.06% 106.33% 98.93% 100.98% 100.73% 99.12% 122.31% 81.18% 104.10% 100.57% 100.74%
Interest Burden Percent
-88.43% 678.32% -64.95% 508.46% 275.42% 121.08% -25.29% 11.90% -121.28% 654.82% -6.24%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 18.82% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
10.39% -2.31% 10.99% -3.64% -9.57% -89.34% 17.34% 31.28% 6.31% -20.97% 37.05%
ROIC Less NNEP Spread (ROIC-NNEP)
4.85% -8.81% 7.40% -8.25% -14.20% -98.05% 14.25% 27.82% 3.44% -31.26% 34.59%
Return on Net Nonoperating Assets (RNNOA)
-3,382.81% -661.16% -27.46% 34.69% 41.25% 204.10% -30.20% -57.77% -6.76% 42.77% -49.34%
Return on Equity (ROE)
-3,372.42% -663.47% -16.47% 31.05% 31.68% 114.76% -12.86% -26.48% -0.45% 21.80% -12.29%
Cash Return on Invested Capital (CROIC)
1.42% 15.92% 12.96% 6.46% 5.29% 21.85% 31.79% 31.27% 25.13% 44.50% 7.37%
Operating Return on Assets (OROA)
4.10% -1.34% 5.62% -2.23% -5.14% -42.81% 7.71% 13.24% 5.16% -7.02% 17.47%
Return on Assets (ROA)
-3.77% -9.69% -3.61% -11.43% -14.25% -51.38% -2.39% 1.28% -6.52% -46.22% -1.10%
Return on Common Equity (ROCE)
-1,660,464.63% 36,752.58% -42.31% 78.06% 46.50% 137.68% -16.49% -33.60% -0.53% 18.71% -11.70%
Return on Equity Simple (ROE_SIMPLE)
-5.06% 0.00% -6.17% 21.24% 28.94% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
5.23 -1.27 5.17 -1.69 -4.50 -37 6.78 12 2.50 -5.75 9.13
NOPAT Margin
6.51% -1.42% 6.50% -2.20% -5.59% -43.57% 8.81% 15.79% 3.17% -6.94% 15.04%
Net Nonoperating Expense Percent (NNEP)
5.54% 6.50% 3.59% 4.61% 4.63% 8.71% 3.09% 3.46% 2.87% 10.30% 2.45%
Return On Investment Capital (ROIC_SIMPLE)
- -1.11% - - - -100.53% 15.63% 26.81% 4.58% -4.30% 6.24%
Cost of Revenue to Revenue
20.23% 26.87% 24.54% 24.44% 27.26% 25.21% 20.90% 18.97% 21.94% 20.40% 11.35%
SG&A Expenses to Revenue
54.59% 59.08% 46.72% 48.34% 57.35% 67.46% 59.24% 31.60% 31.29% 69.56% 49.48%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
70.48% 75.16% 66.17% 78.71% 80.73% 137.03% 66.51% 61.57% 73.54% 89.51% 67.17%
Earnings before Interest and Taxes (EBIT)
5.63 -1.91 6.78 -2.66 -6.48 -52 8.60 14 5.34 -6.93 13
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
11 3.23 13 2.78 -1.27 -47 13 19 11 -2.71 16
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
2.58 1.92 2.40 2.30 1.83 0.00 1.27 1.15 1.21 1.28 0.99
Price to Earnings (P/E)
162.47 0.00 126.42 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.62% 0.00% 0.79% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
5.67 4.86 5.53 5.58 5.04 0.00 6.35 5.79 5.70 8.64 5.90
Enterprise Value to Revenue (EV/Rev)
3.70 2.94 3.47 3.36 2.88 0.00 2.35 2.25 2.35 2.41 2.47
Enterprise Value to EBITDA (EV/EBITDA)
27.23 17.95 13.34 23.29 26.74 0.00 0.00 0.00 0.00 18.58 17.57
Enterprise Value to EBIT (EV/EBIT)
55.25 29.44 22.25 87.17 1,901.64 0.00 0.00 0.00 0.00 36.26 31.73
Enterprise Value to NOPAT (EV/NOPAT)
62.32 38.22 23.61 101.87 892.89 0.00 0.00 0.00 0.00 54.67 45.33
Enterprise Value to Operating Cash Flow (EV/OCF)
21.15 28.54 42.41 104.11 115.36 0.00 50.40 49.70 40.22 26.82 908.15
Enterprise Value to Free Cash Flow (EV/FCFF)
415.61 30.03 45.20 85.95 92.98 0.00 14.55 14.25 18.64 16.39 82.47
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
-4.21 -3.42 -3.54 -3.21 -2.82 -1.79 -1.81 -1.82 -1.84 -1.36 -1.39
Long-Term Debt to Equity
-4.14 -3.37 -3.48 -3.16 -2.77 -1.76 -1.79 -1.80 -1.79 -1.35 -1.38
Financial Leverage
-697.91 75.01 -3.71 -4.20 -2.91 -2.08 -2.12 -2.08 -1.97 -1.37 -1.43
Leverage Ratio
-1,898.89 196.89 -6.94 -8.26 -5.11 -3.23 -3.19 -2.95 -2.53 -1.32 -1.29
Compound Leverage Factor
1,679.10 1,335.56 4.51 -42.01 -14.07 -3.91 0.81 -0.35 3.07 -8.67 0.08
Debt to Total Capital
131.14% 141.40% 139.35% 145.21% 155.04% 226.69% 222.94% 221.44% 218.87% 378.00% 354.12%
Short-Term Debt to Total Capital
2.10% 2.08% 2.21% 2.31% 2.41% 3.52% 3.43% 3.40% 5.89% 3.92% 3.59%
Long-Term Debt to Total Capital
129.04% 139.32% 137.14% 142.90% 152.63% 223.17% 219.51% 218.04% 212.97% 374.07% 350.53%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
24.80% 15.33% 22.78% 22.97% 14.45% 14.74% 17.67% 17.70% 15.57% -76.88% -38.02%
Common Equity to Total Capital
-55.94% -56.73% -62.13% -68.18% -69.48% -141.43% -140.61% -139.13% -134.43% -201.11% -216.10%
Debt to EBITDA
7.97 6.23 3.81 6.86 9.89 -10.67 -10.88 -22.87 -130.77 12.37 12.36
Net Debt to EBITDA
6.69 5.52 3.49 6.31 8.81 -9.66 -9.58 -20.40 -116.32 11.25 11.85
Long-Term Debt to EBITDA
7.84 6.14 3.75 6.75 9.74 -10.50 -10.71 -22.52 -127.25 12.24 12.24
Debt to NOPAT
18.24 13.26 6.74 30.01 330.23 -9.25 -9.82 -15.04 -22.47 36.40 31.90
Net Debt to NOPAT
15.32 11.74 6.17 27.59 294.33 -8.38 -8.65 -13.41 -19.99 33.10 30.58
Long-Term Debt to NOPAT
17.94 13.07 6.63 29.53 325.10 -9.11 -9.67 -14.81 -21.86 36.02 31.58
Altman Z-Score
-0.23 -0.51 -0.28 -0.46 -0.69 0.00 -1.22 -1.22 -1.42 -1.89 -1.99
Noncontrolling Interest Sharing Ratio
-49,136.55% 5,639.43% -156.92% -151.38% -46.78% -19.97% -28.18% -26.86% -18.06% 14.19% 4.81%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.15 0.95 0.95 0.93 1.02 0.78 0.81 0.91 1.06 0.82 0.76
Quick Ratio
0.80 0.67 0.64 0.61 0.72 0.60 0.58 0.67 0.70 0.56 0.43
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-9.88 5.39 -18 0.31 4.55 35 94 86 59 27 1.81
Operating Cash Flow to CapEx
528.69% -470.88% 1,382.05% 146.39% 297.55% 0.00% 1,368.94% 172.93% 914.36% 2,127.09% -8,092.91%
Free Cash Flow to Firm to Interest Expense
-0.93 0.47 -1.54 0.03 0.38 3.03 8.29 6.62 4.56 0.68 0.13
Operating Cash Flow to Interest Expense
0.72 -0.48 0.23 0.27 0.44 0.07 0.51 0.19 0.72 0.27 -1.50
Operating Cash Flow Less CapEx to Interest Expense
0.58 -0.58 0.22 0.08 0.29 0.08 0.47 0.08 0.64 0.26 -1.51
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.59 0.63 0.66 0.64 0.64 0.69 0.69 0.72 0.76 0.84 0.81
Accounts Receivable Turnover
12.73 11.12 11.99 11.51 11.41 10.12 10.39 9.53 13.08 14.21 12.02
Inventory Turnover
4.61 5.77 5.34 6.04 6.07 6.35 6.59 7.01 8.31 10.58 10.27
Fixed Asset Turnover
16.24 16.72 16.97 16.45 16.70 18.76 18.49 19.52 20.35 24.66 23.81
Accounts Payable Turnover
2.93 4.39 3.45 3.08 3.60 3.56 2.95 3.17 3.66 2.43 2.43
Days Sales Outstanding (DSO)
28.67 32.81 30.45 31.73 31.99 36.06 35.12 38.29 27.91 25.69 30.37
Days Inventory Outstanding (DIO)
79.09 63.26 68.39 60.48 60.14 57.49 55.38 52.07 43.94 34.49 35.54
Days Payable Outstanding (DPO)
124.75 83.23 105.95 118.68 101.32 102.45 123.59 115.30 99.62 150.21 150.20
Cash Conversion Cycle (CCC)
-16.98 12.84 -7.10 -26.48 -9.18 -8.90 -33.10 -24.94 -27.77 -90.02 -84.30
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
195 192 205 197 186 120 118 123 130 88 125
Invested Capital Turnover
1.60 1.63 1.69 1.65 1.71 2.05 1.97 1.98 1.99 3.02 2.46
Increase / (Decrease) in Invested Capital
15 -6.66 23 -2.00 -9.05 -72 -88 -74 -56 -32 7.32
Enterprise Value (EV)
1,108 934 1,135 1,099 939 0.00 747 712 741 760 737
Market Capitalization
774 612 785 750 597 0.00 404 365 380 403 295
Book Value per Share
($2.77) ($2.74) ($3.04) ($3.16) ($3.23) ($6.77) ($4.64) ($4.62) ($4.72) ($5.50) ($6.45)
Tangible Book Value per Share
($8.53) ($8.87) ($9.32) ($9.05) ($9.06) ($14.15) ($9.48) ($9.19) ($8.71) ($9.47) ($10.39)
Total Capital
247 229 232 223 224 153 160 162 171 134 146
Total Debt
324 324 324 324 347 347 357 358 375 506 518
Total Long-Term Debt
319 319 319 318 342 342 352 353 365 501 513
Net Debt
272 287 297 298 310 314 314 319 334 460 497
Capital Expenditures (CapEx)
1.44 1.16 0.20 2.05 1.75 -0.17 0.43 1.46 1.02 0.50 0.27
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-31 -38 -27 -27 -31 -51 -60 -43 -25 -62 -40
Debt-free Net Working Capital (DFNWC)
21 -0.49 0.54 -0.96 6.83 -18 -17 -4.70 16 -16 -19
Net Working Capital (NWC)
16 -5.25 -4.61 -6.11 1.43 -24 -23 -10 5.99 -21 -24
Net Nonoperating Expense (NNE)
10 13 9.53 12 13 26 9.43 11 9.24 40 9.95
Net Nonoperating Obligations (NNO)
272 287 297 298 310 314 314 319 334 460 497
Total Depreciation and Amortization (D&A)
5.15 5.15 5.83 5.45 5.21 5.59 4.34 5.34 6.05 4.21 3.11
Debt-free, Cash-free Net Working Capital to Revenue
-10.38% -11.82% -8.15% -8.26% -9.47% -15.95% -18.85% -13.69% -8.05% -19.67% -13.48%
Debt-free Net Working Capital to Revenue
6.93% -0.16% 0.16% -0.29% 2.09% -5.73% -5.45% -1.48% 5.10% -5.11% -6.29%
Net Working Capital to Revenue
5.19% -1.65% -1.41% -1.87% 0.44% -7.41% -7.18% -3.22% 1.90% -6.77% -8.05%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.91 $0.11 ($0.30) ($0.29) ($0.29) ($1.39) ($0.10) ($0.01) ($0.18) ($1.18) ($0.02)
Adjusted Weighted Average Basic Shares Outstanding
32.26M 31.74M 31.13M 31.81M 32.18M 32.00M 33.91M 34.97M 35.11M 34.80M 37.32M
Adjusted Diluted Earnings per Share
($0.50) $1.27 ($0.30) ($0.29) ($0.29) ($1.39) ($0.10) ($0.01) ($0.18) ($1.18) ($0.02)
Adjusted Weighted Average Diluted Shares Outstanding
40.22M 39.71M 31.13M 31.81M 32.18M 32.00M 33.91M 34.97M 35.11M 34.80M 37.32M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
47.46M 47.49M 48.07M 48.18M 48.30M 48.48M 48.67M 48.84M 48.91M 49.05M 49.18M
Normalized Net Operating Profit after Tax (NOPAT)
8.50 -1.27 5.17 6.78 -1.35 -37 8.12 23 15 -5.54 9.13
Normalized NOPAT Margin
10.57% -1.42% 6.50% 8.86% -1.67% -43.57% 10.56% 29.56% 18.77% -6.68% 15.04%
Pre Tax Income Margin
-6.19% -14.51% -5.54% -17.68% -22.16% -75.48% -2.83% 2.18% -8.22% -54.67% -1.34%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.53 -0.17 0.59 -0.24 -0.55 -4.50 0.75 1.07 0.41 -0.18 0.90
NOPAT to Interest Expense
0.49 -0.11 0.45 -0.15 -0.38 -3.15 0.60 0.93 0.19 -0.15 0.63
EBIT Less CapEx to Interest Expense
0.39 -0.27 0.57 -0.42 -0.70 -4.49 0.72 0.96 0.33 -0.19 0.88
NOPAT Less CapEx to Interest Expense
0.36 -0.21 0.43 -0.33 -0.53 -3.13 0.56 0.82 0.11 -0.16 0.61
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
234.62% -300.06% 230.99% -59.03% -39.01% -14.88% -15.25% -20.40% -14.35% -11.50% -8.11%
Augmented Payout Ratio
954.82% -1,081.96% 230.99% -59.03% -39.01% -14.88% -15.25% -20.40% -14.35% -11.50% -8.11%

Financials Breakdown Chart

Key Financial Trends

Xponential Fitness (NYSE:XPOF) showed a much weaker start to 2026, with revenue down sharply from the prior quarter and the company swinging to a loss and a large cash outflow from operations. The latest quarter also reinforces a longer-term theme: XPOF is carrying a highly leveraged balance sheet, with substantial goodwill and intangible assets, while profitability has been inconsistent and cash generation volatile.

  • Cash and equivalents improved to $21.5 million at March 31, 2026, up from $17.8 million at the end of Q4 2025.
  • Inventory was lower than in prior periods, which may help reduce working-capital strain if demand stabilizes.
  • Operating expenses fell meaningfully versus Q4 2025, helping XPOF return to positive operating income of $13.0 million in Q1 2026.
  • The company generated positive operating income in several earlier quarters, showing the underlying franchise model can produce profits when costs are controlled.
  • Deferred revenue remains a meaningful liability, which suggests the business still has a base of prepaid customer revenue to work through.
  • Q1 2026 revenue was $60.7 million, down from $82.9 million in Q4 2025 and $76.2 million in Q2 2025, indicating a softer revenue trend.
  • Gross margin improved in Q1 2026 versus Q4 2025 because cost of revenue dropped faster than sales.
  • The company’s reported common equity remains deeply negative, which is mostly a balance-sheet accounting issue but still reflects a highly burdened capital structure.
  • Goodwill and intangible assets make up a large portion of total assets, so future impairment risk remains something investors should watch.
  • XPOF reported a net loss of $820,000 in Q1 2026, versus a profit in Q2 2025 and a much larger loss in Q4 2025.
  • Operating cash flow was negative $21.7 million in Q1 2026, a steep reversal from positive operating cash flow in Q4 2025.
  • Cash declined by $24.4 million from operating, investing, and financing activities combined in Q1 2026.
  • Long-term debt was still very high at $500.0 million, and total liabilities reached $694.4 million.
  • Interest expense remained heavy at $14.5 million in Q1 2026, overwhelming operating profit and pushing pre-tax income negative.
  • The balance sheet shows negative common equity of $316.3 million, which highlights the company’s leverage and financial risk.

Longer-term trend: XPOF’s last four years show a company that has grown and produced periods of positive operating income, but the path has been uneven. Revenue has generally been in the $70 million to $90 million quarterly range, but earnings have been pressured by high SG&A, marketing, depreciation/amortization, impairment charges, and especially interest expense. The balance sheet has also become more complicated, with large debt balances, sizeable noncontrolling interests, and very large intangible assets.

Bottom line: XPOF’s Q1 2026 results were not disastrous at the operating line, but cash flow and leverage remain the bigger story. Until the company shows more consistent revenue growth, sustained free cash flow, and meaningful debt reduction, the stock is likely to remain highly sensitive to execution and refinancing risk.

07/22/26 10:55 PM ETAI Generated. May Contain Errors.

Xponential Fitness Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Xponential Fitness' financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Xponential Fitness' net income appears to be on an upward trend, with a most recent value of -$53.67 million in 2025, rising from -$37.13 million in 2019. The previous period was -$98.70 million in 2024. View Xponential Fitness' forecast to see where analysts expect Xponential Fitness to go next.

Xponential Fitness' total operating income in 2025 was $19.85 million, based on the following breakdown:
  • Total Gross Profit: $250.13 million
  • Total Operating Expenses: $230.28 million

Over the last 6 years, Xponential Fitness' total revenue changed from $129.13 million in 2019 to $314.88 million in 2025, a change of 143.8%.

Xponential Fitness' total liabilities were at $717.59 million at the end of 2025, a 20.1% increase from 2024, and a 125.6% increase since 2020.

In the past 5 years, Xponential Fitness' cash and equivalents has ranged from $11.30 million in 2020 to $45.86 million in 2025, and is currently $45.86 million as of their latest financial filing in 2025.

Over the last 6 years, Xponential Fitness' book value per share changed from 0.00 in 2019 to -5.50 in 2025, a change of -550.2%.



Financial statements for NYSE:XPOF last updated on 7/2/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners